Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -1.54%

Clover Health Investments, Corp. EBITDA Margin is -1.54% for the Trailing 12 Months (TTM) ending March 31, 2025, a -85.05% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -10.30%, a -11.47% change year over year.
  • Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -11.63%, a -59.10% change year over year.
  • Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -28.44%.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin